Modern trends throughout radiation oncology have favored short-course hypofractionated regimens which are frequently more cost-effective and convenient for patients. Over the past two years, multiple prospective studies have emerged supporting hypofractionation in soft tissue sarcoma.

There is increasing use of sentinel lymph node biopsy in gynecologic cancers but how best to integrate this information into post-operative radiation treatment recommendations is not always clear. This includes how to interpret isolated tumor cells, micrometastasis, and macrometastasis.

For the practical radiation oncology program, this activity includes three speakers for education on the following complex presentations for managing advanced stage gynecologic cancer patients.

This activity focuses on the multidisciplinary care of liver and pancreatic cancer highlighting the role of radiation therapy.

Management of unknown primary head and neck squamous cell carcinomas has evolved as the incidence of p16 positive disease among head and neck cancer patients has increased.

Recent studies have led to radical change in concepts when considering Radiation Therapy for indolent lymphomas. This activity reviews clinical and practical updates in regards to dose considerations, patient selection and radiation techniques for this heterogenous group of patients.

A practicing radiation oncologist increasingly requires knowledge of the business and economic aspects of medical practice.

ASTRO CEO Vivek Kavadi, MD, MBA, FASTRO, conducts a strategic dialogue.
 

Liquid biopsy technologies, particularly circulating tumor DNA (ctDNA), are an emerging tool in precision oncology with growing relevance in radiation oncology.

This activity is designed for radiation oncologists, focusing on managing bone metastases. One of the three presentations exclusively explores stereotactic body radiation therapy (SBRT) for non-spinal bone metastases. Supporting data guides discussions on SBRT's effectiveness and strategies.